Select Page

A blood screening tool for detecting mild cognitive impairment and Alzheimer’s disease among community‐dwelling Mexican Americans and non‐Hispanic Whites: A method for increasing representation of diverse populations in clinical research

June 11, 2021 Abstract Introduction Representation of Mexican Americans in Alzheimer’s disease (AD) clinical research has been extremely poor. Methods Data were examined from the ongoing community-based, multi-ethnic Health & Aging Brain among Latino Elders...

Diet, psychosocial stress, and Alzheimer’s disease–related neuroanatomy in female nonhuman primates

May 14, 2021 Abstract Introduction Associations between diet, psychosocial stress, and neurodegenerative disease, including Alzheimer’s disease (AD), have been reported, but causal relationships are difficult to determine in human studies. Methods We used...

Neuropsychological profile of amyloid‐positive versus amyloid‐negative amnestic Mild Cognitive Impairment

May 6, 2021 Introduction Patients diagnosed with amnestic mild cognitive impairment (aMCI) are at high risk of progressing to dementia. It became possible, through the use of biomarkers, to diagnose those patients with aMCI who have Alzheimer’s disease. However,...

Identification of undiagnosed dementia cases using a web‐based pre‐screening tool: The MOPEAD project

April 23, 2021 Abstract Introduction Innovative patient engagement models are required to identify people with prodromal and mild Alzheimer’s disease who are “hidden” in their communities and not normally found in a memory clinic setting. Methods A marketing...